173 related articles for article (PubMed ID: 24993331)
1. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake.
Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Loft A; Kristensen CA; Specht L
Radiother Oncol; 2014 Jun; 111(3):360-5. PubMed ID: 24993331
[TBL] [Abstract][Full Text] [Related]
2. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
3. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
[TBL] [Abstract][Full Text] [Related]
4. Identifying the location of locoregional recurrences after definitive radiotherapy for head and neck cancer using metabolic parameters of baseline and mid-treatment 18F-FDG-PET scans.
Aren E; Trada Y; Lee M; Deshpande S; Jameson MG; Johnston M; Berry M; Estall V; Fowler A
J Med Imaging Radiat Oncol; 2023 Feb; 67(1):89-97. PubMed ID: 36300564
[TBL] [Abstract][Full Text] [Related]
5. Correlation of [
Pisani C; Vigna L; Mastroleo F; Loi G; Amisano V; Masini L; Deantonio L; Aluffi Valletti P; Sacchetti G; Krengli M
Radiat Oncol; 2021 Mar; 16(1):57. PubMed ID: 33743759
[TBL] [Abstract][Full Text] [Related]
6. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.
Mohamed ASR; Cardenas CE; Garden AS; Awan MJ; Rock CD; Westergaard SA; Brandon Gunn G; Belal AM; El-Gowily AG; Lai SY; Rosenthal DI; Fuller CD; Aristophanous M
Radiother Oncol; 2017 Aug; 124(2):248-255. PubMed ID: 28774596
[TBL] [Abstract][Full Text] [Related]
7. Is image registration of fluorodeoxyglucose-positron emission tomography/computed tomography for head-and-neck cancer treatment planning necessary?
Fried D; Lawrence M; Khandani AH; Rosenman J; Cullip T; Chera BS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):748-54. PubMed ID: 22414285
[TBL] [Abstract][Full Text] [Related]
8. Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
Boeke S; Thorwarth D; Mönnich D; Pfannenberg C; Reischl G; La Fougère C; Nikolaou K; Mauz PS; Paulsen F; Zips D; Welz S
Acta Oncol; 2017 Nov; 56(11):1571-1576. PubMed ID: 28891398
[TBL] [Abstract][Full Text] [Related]
9.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
10. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
11. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
[TBL] [Abstract][Full Text] [Related]
12. Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.
Huang J; Chunta JL; Amin M; Lee DY; Grills IS; Wong CY; Yan D; Marples B; Martinez AA; Wilson GD
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):485-91. PubMed ID: 22331000
[TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.
Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF
Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.
Vernon MR; Maheshwari M; Schultz CJ; Michel MA; Wong SJ; Campbell BH; Massey BL; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):678-84. PubMed ID: 18262086
[TBL] [Abstract][Full Text] [Related]
15. Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.
Moule RN; Kayani I; Prior T; Lemon C; Goodchild K; Sanghera B; Wong WL; Saunders MI
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):364-71. PubMed ID: 21109410
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
17. Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of
van den Bosch S; Dijkema T; Philippens MEP; Terhaard CHJ; Hoebers FJP; Kaanders JHAM; Oyen WJG
Radiother Oncol; 2019 Jan; 130():39-45. PubMed ID: 30005954
[TBL] [Abstract][Full Text] [Related]
18. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
Henriques de Figueiredo B; Barret O; Demeaux H; Lagarde P; De-Mones-Del-Pujol E; Kantor G; de Clermont-Gallerande H; Richaud P; Fernandez P
Radiother Oncol; 2009 Dec; 93(3):479-82. PubMed ID: 19880207
[TBL] [Abstract][Full Text] [Related]
19. Use of
Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
[No Abstract] [Full Text] [Related]
20. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
Yi JS; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY; Roh JL
J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]